Hassan, F.A.; Slone, C.; McDonald, R.J.; Dueber, J.C.; Ashraf, A.M.; Windon, M.J.; Fackelmayer, O.J.; Lee, C.Y.; Bocklage, T.J.; Allison, D.B.
Folliculin (FLCN) in Thyroid Tumors: Incidence, Significance, and Role as a Driver Gene and Secondary Alteration. Curr. Oncol. 2025, 32, 224.
https://doi.org/10.3390/curroncol32040224
AMA Style
Hassan FA, Slone C, McDonald RJ, Dueber JC, Ashraf AM, Windon MJ, Fackelmayer OJ, Lee CY, Bocklage TJ, Allison DB.
Folliculin (FLCN) in Thyroid Tumors: Incidence, Significance, and Role as a Driver Gene and Secondary Alteration. Current Oncology. 2025; 32(4):224.
https://doi.org/10.3390/curroncol32040224
Chicago/Turabian Style
Hassan, Faisal A., Camryn Slone, Robert J. McDonald, Julie C. Dueber, Adeel M. Ashraf, Melina J. Windon, Oliver J. Fackelmayer, Cortney Y. Lee, Therese J. Bocklage, and Derek B. Allison.
2025. "Folliculin (FLCN) in Thyroid Tumors: Incidence, Significance, and Role as a Driver Gene and Secondary Alteration" Current Oncology 32, no. 4: 224.
https://doi.org/10.3390/curroncol32040224
APA Style
Hassan, F. A., Slone, C., McDonald, R. J., Dueber, J. C., Ashraf, A. M., Windon, M. J., Fackelmayer, O. J., Lee, C. Y., Bocklage, T. J., & Allison, D. B.
(2025). Folliculin (FLCN) in Thyroid Tumors: Incidence, Significance, and Role as a Driver Gene and Secondary Alteration. Current Oncology, 32(4), 224.
https://doi.org/10.3390/curroncol32040224
